Trial intelligence / Profile preview

Qihuang Mingmu Recipe in Non-proliferative Diabetic Retinopathy

ChiCTR2100053595Phase 4Recruiting

Sponsor
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Start
Nov 2021
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of Qihuang Mingmu recipe in diabetic retinopathy (NPDR) and type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Incidence, progression and remission of diabetic retinopathy at month 6 and Visual acuity at month 6. Started Nov 2021; status: recruiting.

02

Drugs

Qihuang Mingmu recipe
03

Conditions

diabetic retinopathy (NPDR)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR2100053595.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100053595.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call